← FDA Drug Approvals (Drugs@FDA)

DAKLINZA

NDA · New Drug Application · Sponsor: BRISTOL-MYERS SQUIBB · Approved 2015-07-24

Drug application

FDA Application #

NDA206843

Application type

New Drug Application

Brand name

DAKLINZA

Generic name

Daclatasvir Dihydrochloride

Active ingredients

DACLATASVIR DIHYDROCHLORIDE

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

BRISTOL-MYERS SQUIBB

First approval

2015-07-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown